I. M. Dahl

904 total citations · 1 hit paper
12 papers, 674 citations indexed

About

I. M. Dahl is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, I. M. Dahl has authored 12 papers receiving a total of 674 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 4 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in I. M. Dahl's work include Multiple Myeloma Research and Treatments (3 papers), Proteoglycans and glycosaminoglycans research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). I. M. Dahl is often cited by papers focused on Multiple Myeloma Research and Treatments (3 papers), Proteoglycans and glycosaminoglycans research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). I. M. Dahl collaborates with scholars based in Norway, Sweden and Denmark. I. M. Dahl's co-authors include Anna Engström‐Laurent, Kirsti Granath, Lauritz Bredrup Dahl, Gunnar Husby, Peter Gimsing, Lene Meldgaard Knudsen, Nina Gulbrandsen, Johan Lanng Nielsen, Ingerid Nesthus and Ingemar Turesson and has published in prestigious journals such as Annals of the Rheumatic Diseases, Experimental Cell Research and Haematologica.

In The Last Decade

I. M. Dahl

12 papers receiving 643 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies.

1985 460 citations Lauritz Bredrup Dahl, I. M. Dahl et al. Annals of the Rheumatic Diseases profile →

Peers

I. M. Dahl

RHEUM

CB

MB

SURGE

HEMAT

Michael E. J. Billingham United Kingdom

Mireille Thomas France

D. P. Page Thomas United Kingdom

Kei Sakao Japan

Alan M. Appel United States

B. Harrach Germany

Susan Donatelli United States

Mark Bolton United Kingdom

Klaus Bobacz Austria

Mary Louise Stover United States

Michael E. J. Billingham United Kingdom

I. M. Dahl

590 ×2.0

RHEUM

172 ×0.6

CB

115 ×0.7

MB

248 ×1.9

SURGE

28 ×0.2

HEMAT

Citations per year, relative to I. M. Dahl I. M. Dahl (= 1×) peers Michael E. J. Billingham

Countries citing papers authored by I. M. Dahl

Since Specialization

Citations

This map shows the geographic impact of I. M. Dahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. M. Dahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. M. Dahl more than expected).

Fields of papers citing papers by I. M. Dahl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. M. Dahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. M. Dahl. The network helps show where I. M. Dahl may publish in the future.

Co-authorship network of co-authors of I. M. Dahl

This figure shows the co-authorship network connecting the top 25 collaborators of I. M. Dahl. A scholar is included among the top collaborators of I. M. Dahl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. M. Dahl. I. M. Dahl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Rasmussen, T., Jacob Haaber, I. M. Dahl, et al.. (2010). Identification of translocation products but not K-RAS mutations in memory B cells from patients with multiple myeloma. Haematologica. 95(10). 1730–1737. 38 indexed citations

2.

Gulbrandsen, Nina, Anders Waage, Peter Gimsing, et al.. (2008). A Randomised Placebo Controlled Study With Melphalan/Prednisone Vs Melphalan/Prednisone/Thalidomide: Quality Of Life And Toxicity. Lund University Publications (Lund University). 93. 209–209. 16 indexed citations

3.

Skjelbakken, Tove, Maja‐Lisa Løchen, & I. M. Dahl. (2002). Haematological malignancies in a general population, based on information collected from a population study, hospital records, and the Cancer Registry of Norway. European Journal Of Haematology. 69(2). 67–75. 7 indexed citations

4.

Gulbrandsen, Nina, Finn Wislöff, Lorentz Brinch, et al.. (2001). Health-Related Quality of Life in Multiple Myeloma Patients Receiving High-Dose Chemotherapy with Autologous Blood Stem-Cell Support. Medical Oncology. 18(1). 65–78. 73 indexed citations

5.

Rasmussen, T., I. M. Dahl, Louise Helene Søgaard Jensen, & Hans Erik Johnsen. (2000). CD68+/CD83+/CD1a− dendritic cell subsets from patients with multiple myeloma are not infected with human herpesvirus 8. Medical Oncology. 17(3). 189–194. 2 indexed citations

6.

Tangen, Jon‐Magnus, et al.. (1999). [Empirical antibiotic treatment of patients with acute myelogenous leukemia].. PubMed. 119(1). 35–8. 2 indexed citations

7.

Tangen, Jon‐Magnus, Finn Wislöff, Michael Abdelnoor, et al.. (1997). Survival in 86 patients, aged 15–60, with primary acute myelogenous leukemia, treated with a common program in the Norwegian health regions I, III, IV and V in the period 1990–1995. European Journal Of Haematology. 59(2). 110–114. 1 indexed citations

8.

Hellström‐Lindberg, Eva, Martin Carlsson, Jan Carneskog, et al.. (1994). Synergistic effect of G-CSF and epo on the anaemia in patients with MDS. Evidence for increased erythropoietic effectiveness rather than expansion. Leukemia Research. 18. 17–17. 1 indexed citations

9.

Dahl, I. M. & Gunnar Husby. (1985). Hyaluronic acid production in vitro by synovial lining cells from normal and rheumatoid joints.. Annals of the Rheumatic Diseases. 44(10). 647–657. 48 indexed citations

10.

Dahl, Lauritz Bredrup, I. M. Dahl, Anna Engström‐Laurent, & Kirsti Granath. (1985). Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies.. Annals of the Rheumatic Diseases. 44(12). 817–822. 460 indexed citations breakdown →

11.

Dahl, I. M., et al.. (1974). The synthesis of glycosaminoglycans by corneal stroma cells in culture. Experimental Cell Research. 88(1). 193–197. 20 indexed citations

12.

Angervall, Lennart, I. M. Dahl, & J Säve-Söderbergh. (1966). The aortic vasa vasorum in juvenile diabetes.. PubMed. 29(4). 431–7. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact